JENNIFER CHIEPPA: Open Payments
NPI 1124402904 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,065 in 111 payments from 38 companies in 2025. Trend: 2023 $2,029 · 2024 $2,483 · 2025 $3,065
Food & beverage: $1,844Long term medical supply or device loan: $1,000Education: $221
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $1,146 |
| ABBVIE INC. | 12 | $219 |
| Incyte Corporation | 5 | $177 |
| Daiichi Sankyo Inc. | 4 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $133 |
| PFIZER INC. | 7 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| Aveo Pharmaceuticals, Inc. | 3 | $84 |
| GlaxoSmithKline, LLC. | 4 | $78 |
Products named: KISQALI, Enhertu, FRUZAQLA, IBRANCE, FOTIVDA, ELAHERE, JAKAFI, Nubeqa.
Industry payments across NJ — which companies pay providers there.
